189 related articles for article (PubMed ID: 38685844)
21. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil.
Zaltman C; Parra RS; Sassaki LY; Santana GO; Ferrari MLA; Miszputen SJ; Amarante HMBS; Kaiser Junior RL; Flores C; Catapani WR; Parente JML; Bafutto M; Ramos O; Gonçalves CD; Guimaraes IM; da Rocha JJR; Feitosa MR; Feres O; Saad-Hossne R; Penna FGC; Cunha PFS; Gomes TN; Nones RB; Faria MAG; Parente MPPD; Scotton AS; Caratin RF; Senra J; Chebli JM
World J Gastroenterol; 2021 Jan; 27(2):208-223. PubMed ID: 33510560
[TBL] [Abstract][Full Text] [Related]
22. Retrospective survey of 452 patients with inflammatory bowel disease in Wuhan city, central China.
Jiang L; Xia B; Li J; Ye M; Yan W; Deng C; Ding Y; Luo H; Hou W; Zhao Q; Liu N; Ren H; Hou X; Xu H
Inflamm Bowel Dis; 2006 Mar; 12(3):212-7. PubMed ID: 16534423
[TBL] [Abstract][Full Text] [Related]
23. The Influence of Antidepressants on the Disease Course Among Patients With Crohn's Disease and Ulcerative Colitis-A Danish Nationwide Register-Based Cohort Study.
Kristensen MS; Kjærulff TM; Ersbøll AK; Green A; Hallas J; Thygesen LC
Inflamm Bowel Dis; 2019 Apr; 25(5):886-893. PubMed ID: 30551218
[TBL] [Abstract][Full Text] [Related]
24. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
25. Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study.
Biancone L; Zuzzi S; Ranieri M; Petruzziello C; Calabrese E; Onali S; Ascolani M; Zorzi F; Condino G; Iacobelli S; Pallone F
J Crohns Colitis; 2012 Jun; 6(5):578-87. PubMed ID: 22398047
[TBL] [Abstract][Full Text] [Related]
26. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis.
Ananthakrishnan AN; Long MD; Martin CF; Sandler RS; Kappelman MD
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):965-71. PubMed ID: 23376797
[TBL] [Abstract][Full Text] [Related]
27. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
[TBL] [Abstract][Full Text] [Related]
28. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database.
Vind I; Riis L; Jess T; Knudsen E; Pedersen N; Elkjaer M; Bak Andersen I; Wewer V; Nørregaard P; Moesgaard F; Bendtsen F; Munkholm P;
Am J Gastroenterol; 2006 Jun; 101(6):1274-82. PubMed ID: 16771949
[TBL] [Abstract][Full Text] [Related]
29. [Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].
Lakatos L; Mester G; Erdélyi Z; Balogh M; Szipócs I; Kamarás G; Lakatos PL
Orv Hetil; 2003 Sep; 144(37):1819-27. PubMed ID: 14596020
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of Iranian pediatric patients with inflammatory bowel disease.
Fallahi GH; Moazzami K; Tabatabaeiyan M; Zamani MM; Asgar-Shirazi M; Najafi M; Motamed F; Farahmand F; Khodad A; Khatami GR; Rezaei N
Acta Gastroenterol Belg; 2009; 72(2):230-4. PubMed ID: 19637779
[TBL] [Abstract][Full Text] [Related]
31. Emerging inflammatory bowel disease demographics, phenotype, and treatment in South Asia, South-East Asia, and Middle East: Preliminary findings from the Inflammatory Bowel Disease-Emerging Nations' Consortium.
Banerjee R; Pal P; Hilmi I; Ghoshal UC; Desai DC; Rahman MM; Dutta U; Mohiuddin SA; Al Mohannadi M; Philip M; Ramesh GN; Niriella MA; De Silva AP; de Silva HJ; Pisespongsa P; Limsrivilai J; Aniwan S; Nawarathne M; Fernandopulle N; Aye TT; Ni N; Al Awadhi S; Joshi N; Ngoc PTV; Kieu TV; Nguyen AD; Abdullah M; Ali E; Zeid A; Sollano JD; Saberi B; Omar M; Mohsin MN; Aftab H; Wai TM; Shastri YM; Chaudhuri S; Ahmed F; Bhatia SJ; Travis SPL;
J Gastroenterol Hepatol; 2022 Jun; 37(6):1004-1015. PubMed ID: 35178742
[TBL] [Abstract][Full Text] [Related]
32. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
33. Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital.
Sofia MA; Rubin DT; Hou N; Pekow J
Dig Dis Sci; 2014 Sep; 59(9):2228-35. PubMed ID: 24752402
[TBL] [Abstract][Full Text] [Related]
34. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
35. Risk Factors for Extraintestinal Manifestations in Inflammatory Bowel Diseases - Data from the Romanian National Registry.
Singeap AM; Girleanu I; Diculescu M; Gheorghe L; Ciocîrlan M; Gheorghe C; Costache A; Tanțău A; Zaharie R; Goldis A; Gheonea D; Dobru D; Dumitru E; Prelipcean CC; Gîlcă-Blanariu GE; Moscalu M; Stanciu C; Trifan A
J Gastrointestin Liver Dis; 2021 Sep; 30(3):346-357. PubMed ID: 34375380
[TBL] [Abstract][Full Text] [Related]
36. Changing phenotype, early clinical course and clinical predictors of inflammatory bowel disease in Sri Lanka: a retrospective, tertiary care-based, multi-centre study.
Niriella MA; Liyanage IK; Kodisinghe SK; De Silva AP; Jayatissa AVGAM; Navarathne NMM; Peiris RK; Kalubovila UP; Kumarasena SR; Jayasekara RW; de Silva HJ
BMC Gastroenterol; 2021 Feb; 21(1):71. PubMed ID: 33593289
[TBL] [Abstract][Full Text] [Related]
37. Influence of phenotype at diagnosis and of other potential prognostic factors on the course of inflammatory bowel disease.
Romberg-Camps MJ; Dagnelie PC; Kester AD; Hesselink-van de Kruijs MA; Cilissen M; Engels LG; Van Deursen C; Hameeteman WH; Wolters FL; Russel MG; Stockbrügger RW
Am J Gastroenterol; 2009 Feb; 104(2):371-83. PubMed ID: 19174787
[TBL] [Abstract][Full Text] [Related]
38. Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases.
Halling ML; Kjeldsen J; Knudsen T; Nielsen J; Hansen LK
World J Gastroenterol; 2017 Sep; 23(33):6137-6146. PubMed ID: 28970729
[TBL] [Abstract][Full Text] [Related]
39. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
40. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
